Jie Ling

Jie Ling practices at Bay Area Union Health Center in Millbrae, California.

Jie Ling's NPI, 1003187766, was assigned on January 25, 2012. Jie Ling graduated from West China University of Medical Sciences in 1992. Jie Ling holds California license A130461.

Jie Ling's primary practice is Bay Area Union Health Center, at 101 El Camino Real, Millbrae, CA 94030-2605. The practice phone is (650) 651-7175.

Jie Ling's primary practice is Bay Area Union Health Center in Millbrae, California. Jie Ling is also affiliated with Mills-Peninsula Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Jie Ling practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Jie Ling's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Jie Ling is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Jie Ling's licenses on file in 2 states: California and Maryland.

Dmand AI lists acute sinusitis, anxiety, arteritis, asthma, atrial fibrillation and flutter, bronchitis, cerebrovascular disease and chronic anemia among the conditions Jie Ling treats.

CMS data shows 754 Medicare services from Jie Ling across 12 procedure codes in 2024, for 110 Medicare patients. Medicare paid $58,382 for them. Every service was in an office.

CMS counts 110 Medicare patients who saw Jie Ling in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jie Ling's median patient age at 54, with 61% women.

In 2024, Jie Ling wrote 4,713 Medicare Part D claims for 387 patients. 91% of them were for generic drugs. CMS names the drug for 4,269 of them, across 64 drugs with 11 or more claims each, at $404,854 in total drug cost. In 2023, CMS named 4,170 claims across 68 drugs.

Jie Ling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jie Ling as offering telehealth.

Dmand AI links 6 papers to Jie Ling, published from 2005 to 2013. The most frequent topics are Erlotinib Hydrochloride, Quinazolines and Antineoplastic Agents. Jie Ling has published most often in Anticancer Drugs. Jie Ling's most frequent co-authors are Mark R. Albertini, MD, Prasanta Basak, MD and Roger N. Coron, MD.

Dmand AI links Jie Ling to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 337 general payments to Jie Ling from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,849.

Jie Ling graduated from West China University of Medical Sciences in 1992.

Jie Ling is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.